Argireline (Acetyl Hexapeptide-3, Acetyl Hexapeptide-8) — Peptide Encyclopedia | RetatrutideCompare

Mimics the N-terminus of SNAP-25 and competes for SNARE complex assembly, dampening neurotransmitter release at the neuromuscular junction (proposed wrinkle-reduction mechanism).

Reference facts

Also known as
Acetyl Hexapeptide-3, Acetyl Hexapeptide-8
Category
Cosmetic & Skin
Mechanism of action
Mimics the N-terminus of SNAP-25 and competes for SNARE complex assembly, dampening neurotransmitter release at the neuromuscular junction (proposed wrinkle-reduction mechanism).
Targets
SNARE complex (in vitro)
Indications under research or approved
Cosmetic anti-wrinkle topical formulations
Regulatory status (reference entry)
Cosmetic ingredient; not FDA-approved as drug
Half-life
Minutes (topical, local action)
Sequence
EEMQRR
Sequence notes
Hexapeptide Ac-Glu-Glu-Met-Gln-Arg-Arg-NH2; mimics the N-terminus of SNAP-25.
Molecular weight (Da)
889
Originator / sponsor
Lipotec / Lubrizol
First reported
2002

Primary References

Explore research articles about Argireline

This is an educational reference, not medical advice. Research findings do not establish safety or efficacy for self-administration. Consult the primary sources for study populations, limitations, and current regulatory status.